Sitemap
Reza Zahiri

Reza Zahiri

Technology executive | Imaging & AI | Author, Decoding MedTech | The strategy and finances of MedTech, pharma and industrial companies, explained in charts

๐‡๐จ๐ฐ ๐†๐„โ€™๐ฌ ๐’๐ฉ๐ฅ๐ข๐ญ ๐๐ซ๐จ๐ฎ๐ ๐ก๐ญ ๐๐ž๐ฐ ๐‹๐ข๐Ÿ๐ž ๐ญ๐จ ๐ˆ๐ญ๐ฌ ๐‹๐ž๐ ๐š๐œ๐ฒ

2 min readNov 25, 2024

General Electric (GE), one of the most iconic conglomerates in American history, faced significant financial challenges in the early 21st century. Over the last two decades, the companyโ€™s expansive diversification across multiple sectors, including aviation, healthcare, energy, and financial services, led to significant operational complexities and inefficiencies. By 2020, GEโ€™s valuation had declined to approximately $100B, an almost 80% drop from its peak market cap in 2000.

In response to these challenges, in 2021, the company announced plans to split into three distinct entities:

  1. GE Aerospace: Focusing on aviation technologies,
  2. GE Vernova: Dedicated to energy solutions,
  3. GE HealthCare: Concentrating on medical technologies and services.

The split was completed in April 2024, 132 years after GE was founded. The restructuring aimed to enhance leadership focus, streamline operations, and allow each entity to pursue tailored growth strategies.

Get Reza Zahiriโ€™s stories inย yourย inbox

Join Medium for free to get updates fromย thisย writer.

Today, the three entities work independently and have a combined valuation of over $300B. That is over three times more than the valuation of GE before the split and close to its peak valuation in 2000. GEโ€™s split is perhaps one of the most notable cases of breaking down large conglomerates that unlocked significant shareholder value.

Press enter or click to view image in full size

Views and ideas are my own. The content I provide here is all public data intended to be educational only and is not financial advice. I encourage the readers to do their research.

--

--

Reza Zahiri
Reza Zahiri

Written by Reza Zahiri

Technology executive | Imaging & AI | Author, Decoding MedTech | The strategy and finances of MedTech, pharma and industrial companies, explained in charts